'''Oxolinic acid''' is a [[Quinolone antibiotic|quinolone]] [[antibiotic]] developed in Japan in the 1970s.<ref>JP Patent 49138244</ref><ref name="pmid384788">{{cite journal |vauthors=Gleckman R, Alvarez S, Joubert DW, Matthews SJ |title=Drug therapy reviews: oxolinic acid |journal=American Journal of Hospital Pharmacy |volume=36 |issue=8 |pages=1077–9 |date=August 1979 |pmid=384788 |doi= |url= }}</ref> Dosages 12–20&nbsp;mg/kg orally administered for five to ten days.  The antibiotic works by inhibiting the enzyme [[DNA gyrase]]. It also acts as a [[dopamine reuptake inhibitor]] and has stimulant effects in mice.<ref name="pmid9928913">{{cite journal |vauthors=Garcia de Mateos-Verchere J, Vaugeois JM, Naudin B, Costentin J |title=Behavioural and neurochemical evidence that the antimicrobial agent oxolinic acid is a dopamine uptake inhibitor |journal=European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology |volume=8 |issue=4 |pages=255–9 |date=December 1998 |pmid=9928913 |doi= 10.1016/S0924-977X(97)00083-7|url=http://linkinghub.elsevier.com/retrieve/pii/S0924-977X(97)00083-7}}</ref>
